Physician profile
Jeffrey Lewis
NPI 1801142351
$393,897.69
in general payments reported to CMS, 2019-2025
7 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $25K · 2021: $38K · 2022: $82K · 2023: $102K · 2024: $101K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $159K · Travel and Lodging: $60K · Food and Beverage: $9,628 · Consulting Fee: $5,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $158,997.25 |
| Travel and Lodging | $60,351.58 |
| Food and Beverage | $9,627.64 |
| Consulting Fee | $5,850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $314,129.32 | 2022-2025 | Infuse, Infuse Multifocal, Ultra Multifocal Toric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76,653.06 | 2019-2021 | |
| Alcon Vision LLC | $2,637.98 | 2019-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Abbvie INC. | $221.47 | 2022-2023 | |
| Coopervision INC. | $121.98 | 2019-2023 | Biofinity Contact Lens, Myday Contact Lens |
| Harrow Eye, LLC | $120.42 | 2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.